Awada, A., Hammoud, A., Ali, A. H., Soueid, L., Jaber, F., Rammal, F., Rizkallah, J., Khaled, A., Faraj, S., Mashmoushi, N., Madi, M., Tarhini, A., Kteich, K., Hassan, M., Charbel, N., Kreidieh, F. Y. (2026). Clinical impact of baseline and peri-treatment concomitant medication exposure and polypharmacy on outcomes of immune checkpoint inhibitor therapy: A real-world pan-tumor analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11011